Herceptin (Trastuzumab) for Breast Cancer Treatment
Herceptin (Trastuzumab) for Breast Cancer Treatment: Quick Links
Important Safety Information
Adjuvant Breast Cancer
Metastatic Breast Cancer
Full Prescribing Information
Switch to Healthcare Professionals
Share your Herceptin Story
Herceptin (Trastuzumab) and Breast Cancer: Patients and Caregivers
This site is intended for US Residents only. If you are not a US Resident, please click here.
Herceptin (Trastuzumab) Go to Patient and Caregiver Site Herceptin (Trastuzumab): Go to Healthcare Professional Site English  |   Español
Search this site: Text Size: Herceptin (Trastuzumab) for Breast Cancer Treatment: Increase Font Size Herceptin (Trastuzumab) for Breast Cancer Treatment: Decrease Font Size Herceptin (Trastuzumab) for Breast Cancer Treatment: Print Page Print Page Herceptin (Trastuzumab) for Breast Cancer Treatment: Email Page E-Mail Page
Herceptin (Trastuzumab) Breast Cancer: Foundation

Terms

BY USING THIS SITE YOU ACKNOWLEDGE THAT GENENTECH, INC. IS PROVIDING THE MATERIAL FOR INFORMATIONAL PURPOSES ONLY AND THAT NEITHER GENENTECH, INC. NOR THEIR AGENTS, AFFILIATES, PARTNERS, OR LICENSORS ARE PROVIDING THE MATERIALS TO YOU FOR THE PURPOSES OF GIVING YOU MEDICAL ADVICE. YOU SHOULD NOT RELY ON THE MATERIALS IN DECIDING ON A TREATMENT PLAN, DRUG USAGE, OR ANY OTHER MEDICAL ADVICE REGARDING THE MATERIALS, AND GENENTECH, INC., AND THEIR LICENSORS STRONGLY URGE THAT YOU CONSULT WITH A PHYSICIAN IN CONNECTION WITH ANY AND ALL TREATMENT OPTIONS THAT MAY BE AVAILABLE TO YOU.

BY USING THIS WEBSITE, YOU ACCEPT THE INFORMATION, PRODUCTS, AND SERVICES PROVIDED HEREIN "AS IS". GENENTECH, INC., MAKES NO EXPRESS OR IMPLIED WARRANTY REGARDING THE ACCURACY, CONTENT, COMPLETENESS, RELIABILITY, OPERABILITY, OR LEGALITY OF INFORMATION CONTAINED WITHIN THIS WEBSITE, INCLUDING, WITHOUT LIMITATION, THE WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT OF PROPRIETARY RIGHTS.

IN NO EVENT SHALL GENENTECH, INC., OR ITS AGENTS, AFFILIATES, PARTNERS, OR LICENSORS BE LIABLE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL OR CONSEQUENTIAL DAMAGES OR ANY DAMAGES WHATSOEVER RESULTING FROM LOSS RELATED TO THE USE OF OUR WEBSITES, WHETHER IN AN ACTION OF CONTRACT, BREACH OF WARRANTY, NEGLIGENCE, OR OTHER TORTIOUS ACTION ARISING OUT OF OR IN CONNECTION WITH THE USE OF THE MATERIALS CONTAINED ON THIS SITE.
Herceptin (Trastuzumab) Breast Cancer Terms: Print Page
Herceptin (Trastuzumab) for Breast Cancer Treatment: Privacy Policy Herceptin (Trastuzumab) for Breast Cancer Treatment: Terms and Conditions Herceptin (Trastuzumab) for Breast Cancer Treatment: Prescribing Information Herceptin (Trastuzumab) for Breast Cancer Treatment: Safety Information Herceptin (Trastuzumab) for Breast Cancer Treatment: Site Map Herceptin (Trastuzumab) for Breast Cancer Treatment: Contact Information
Genentech BioOncology © 2008 Genentech, Inc. All rights reserved. This site intended for US residents only.